December 3, 2012
The Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) First Committee on Drugs on November 30 recommended approval for seven products/indications, including Bristol-Myers K.K.’s novel oral factor Xa inhibitor Eliquis Tablets 2.5 mg/5 mg (apixaban). Eliquis, an anticoagulant agent, is a...read more